{"id":"https://openalex.org/W4322492433","doi":"https://doi.org/10.1007/s12274-023-5474-8","title":"A boronic acid conjugation integrates antitumor drugs into albumin-binding prodrugs-based nanoparticles with robust efficiency for cancer therapy","display_name":"A boronic acid conjugation integrates antitumor drugs into albumin-binding prodrugs-based nanoparticles with robust efficiency for cancer therapy","alternate_titles":[],"publication_year":2023,"publication_date":"2023-02-27","ids":{"openalex":"https://openalex.org/W4322492433","doi":"https://doi.org/10.1007/s12274-023-5474-8"},"language":"en","primary_location":{"id":"doi:10.1007/s12274-023-5474-8","doi":"https://doi.org/10.1007/s12274-023-5474-8","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12274-023-5474-8","pdf_url":null,"source":{"id":"https://openalex.org/S173461644","display_name":"Nano Research","issn_l":"1998-0000","issn":["1998-0000","1998-0124"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-2","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nano Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4322492433"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011498884","display_name":"Weiyue Ban","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I103890011","display_name":"Shenyang Pharmaceutical University","ror":"https://ror.org/03dnytd23","country_code":"CN","type":"education","lineage":["https://openalex.org/I103890011"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Weiyue Ban","raw_affiliation_strings":["Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China","institution_ids":["https://openalex.org/I103890011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078717176","display_name":"Qiuhua Luo","orcid":"https://orcid.org/0000-0003-3545-2499","observed_orcids":["https://orcid.org/0000-0003-3545-2499"]},"institutions":[{"id":"https://openalex.org/I4210140515","display_name":"First Hospital of China Medical University","ror":"https://ror.org/04wjghj95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140515"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qiuhua Luo","raw_affiliation_strings":["Department of Pharmacy, The First Hospital of China Medical University, Shenyang, 110001, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, The First Hospital of China Medical University, Shenyang, 110001, China","institution_ids":["https://openalex.org/I4210140515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003593973","display_name":"Chengda Yan","orcid":"https://orcid.org/0000-0003-2546-5720","observed_orcids":["https://orcid.org/0000-0003-2546-5720"]},"institutions":[{"id":"https://openalex.org/I4210140515","display_name":"First Hospital of China Medical University","ror":"https://ror.org/04wjghj95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140515"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chengda Yan","raw_affiliation_strings":["Phase I Clinical Trials Center, The First Hospital of China Medical University, Shenyang, 110102, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phase I Clinical Trials Center, The First Hospital of China Medical University, Shenyang, 110102, China","institution_ids":["https://openalex.org/I4210140515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101508303","display_name":"Xiaoying Fan","orcid":"https://orcid.org/0000-0002-2599-8319","observed_orcids":["https://orcid.org/0000-0002-2599-8319"]},"institutions":[{"id":"https://openalex.org/I4210140515","display_name":"First Hospital of China Medical University","ror":"https://ror.org/04wjghj95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140515"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaoying Fan","raw_affiliation_strings":["Phase I Clinical Trials Center, The First Hospital of China Medical University, Shenyang, 110102, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phase I Clinical Trials Center, The First Hospital of China Medical University, Shenyang, 110102, China","institution_ids":["https://openalex.org/I4210140515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101014066","display_name":"Guorui Zhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I103890011","display_name":"Shenyang Pharmaceutical University","ror":"https://ror.org/03dnytd23","country_code":"CN","type":"education","lineage":["https://openalex.org/I103890011"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Guorui Zhu","raw_affiliation_strings":["Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China","institution_ids":["https://openalex.org/I103890011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086779479","display_name":"Maosheng Cheng","orcid":"https://orcid.org/0000-0001-9073-4806","observed_orcids":["https://orcid.org/0000-0001-9073-4806","https://orcid.org/0000-0002-0502-6133"]},"institutions":[{"id":"https://openalex.org/I103890011","display_name":"Shenyang Pharmaceutical University","ror":"https://ror.org/03dnytd23","country_code":"CN","type":"education","lineage":["https://openalex.org/I103890011"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Maosheng Cheng","raw_affiliation_strings":["Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China","institution_ids":["https://openalex.org/I103890011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100420129","display_name":"Zhonggui He","orcid":"https://orcid.org/0000-0002-5907-3875","observed_orcids":["https://orcid.org/0000-0002-5907-3875","https://orcid.org/0000-0002-4172-7527"]},"institutions":[{"id":"https://openalex.org/I103890011","display_name":"Shenyang Pharmaceutical University","ror":"https://ror.org/03dnytd23","country_code":"CN","type":"education","lineage":["https://openalex.org/I103890011"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhonggui He","raw_affiliation_strings":["Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China","institution_ids":["https://openalex.org/I103890011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032107299","display_name":"Mengchi Sun","orcid":"https://orcid.org/0000-0002-7457-3499","observed_orcids":["https://orcid.org/0000-0002-7457-3499"]},"institutions":[{"id":"https://openalex.org/I103890011","display_name":"Shenyang Pharmaceutical University","ror":"https://ror.org/03dnytd23","country_code":"CN","type":"education","lineage":["https://openalex.org/I103890011"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Mengchi Sun","raw_affiliation_strings":["School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China","institution_ids":["https://openalex.org/I103890011"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5114011444","display_name":"Jin Yuan Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I103890011","display_name":"Shenyang Pharmaceutical University","ror":"https://ror.org/03dnytd23","country_code":"CN","type":"education","lineage":["https://openalex.org/I103890011"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jin Sun","raw_affiliation_strings":["Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China","institution_ids":["https://openalex.org/I103890011"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5032107299","https://openalex.org/A5114011444"],"corresponding_institution_ids":["https://openalex.org/I103890011"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":0.2268,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.2770787,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"16","issue":"5","first_page":"7422","last_page":"7430"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phenylboronic-acid","display_name":"phenylboronic acid","score":0.8429999947547913},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9100000262260437},{"id":"https://openalex.org/keywords/albumin-based-nanoparticles","display_name":"albumin-based nanoparticles","score":0.9020000100135803},{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.9179999828338623},{"id":"https://openalex.org/keywords/nanoprecipitation","display_name":"nanoprecipitation","score":0.8600000143051147},{"id":"https://openalex.org/keywords/colloidal-stability","display_name":"colloidal stability","score":0.9539999961853027},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.5770000219345093},{"id":"https://openalex.org/keywords/lung-metastasis","display_name":"lung metastasis","score":0.7059999704360962},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8199999928474426},{"id":"https://openalex.org/keywords/breast-tumors","display_name":"breast tumors","score":0.8180000185966492},{"id":"https://openalex.org/keywords/cancer-nanomedicine","display_name":"cancer nanomedicine","score":0.8640000224113464},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.765999972820282}],"concepts":[{"id":"https://openalex.org/C2777734296","wikidata":"https://www.wikidata.org/wiki/Q408739","display_name":"Phenylboronic acid","level":3,"score":0.7448022365570068},{"id":"https://openalex.org/C2776125364","wikidata":"https://www.wikidata.org/wiki/Q169219","display_name":"Albumin","level":2,"score":0.7374734282493591},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.7241547703742981},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6733152270317078},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6246989965438843},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5803174376487732},{"id":"https://openalex.org/C2777864310","wikidata":"https://www.wikidata.org/wiki/Q335768","display_name":"Boronic acid","level":2,"score":0.5204092264175415},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4892847239971161},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.42347198724746704},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3617597222328186},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.25513774156570435},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23290681838989258},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1917210817337036},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.07525953650474548},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06315922737121582},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/s12274-023-5474-8","doi":"https://doi.org/10.1007/s12274-023-5474-8","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12274-023-5474-8","pdf_url":null,"source":{"id":"https://openalex.org/S173461644","display_name":"Nano Research","issn_l":"1998-0000","issn":["1998-0000","1998-0124"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-2","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nano Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W1963618034","https://openalex.org/W2021397298","https://openalex.org/W2045683699","https://openalex.org/W2074473216","https://openalex.org/W2132525235","https://openalex.org/W2144536924","https://openalex.org/W2237082602","https://openalex.org/W2407297656","https://openalex.org/W2461657244","https://openalex.org/W2474139868","https://openalex.org/W2594239688","https://openalex.org/W2783404219","https://openalex.org/W2883860383","https://openalex.org/W2951794613","https://openalex.org/W2977603888","https://openalex.org/W3014614371","https://openalex.org/W3037791971","https://openalex.org/W3093408685","https://openalex.org/W3111957298","https://openalex.org/W3165580924","https://openalex.org/W4213324290","https://openalex.org/W4295025003"],"related_works":["https://openalex.org/W3112755618","https://openalex.org/W4402894084","https://openalex.org/W3120573232","https://openalex.org/W2963128545","https://openalex.org/W3155848991","https://openalex.org/W2791483073","https://openalex.org/W2144378910","https://openalex.org/W7169764052","https://openalex.org/W2021257536","https://openalex.org/W4403458394"],"abstract_inverted_index":{"Despite":[0],"great":[1,121],"therapeutic":[2],"effect":[3],"of":[4,17,48,63,111,132,138,147,163,180],"Abraxane\u00ae,":[5],"complex":[6],"preparation":[7],"technology":[8],"and":[9,104,123,141,144,154,172],"unfavorable":[10],"pharmacokinetics":[11],"still":[12],"restricted":[13],"the":[14,36,40,46,61,72,112,116,128,136,161,168,177],"clinical":[15],"application":[16],"albumin-based":[18,56,83,91,117,169,181],"paclitaxel":[19],"(PTX)":[20],"nanoparticles":[21],"(NPs).":[22],"Herein,":[23],"we":[24],"reported":[25],"that":[26,82],"an":[27,158],"albumin-binding":[28],"prodrug,":[29],"phenylboronic":[30,164],"acid-conjugated":[31],"PTX":[32,69,92,170],"(P-PTX),":[33],"can":[34],"form":[35],"uniform":[37],"NPs":[38,85,93,119],"with":[39,45,68,120],"diameters":[41],"around":[42],"100":[43],"nm":[44],"help":[47],"albumin":[49],"via":[50],"simple":[51],"one-step":[52,95],"nano-precipitation":[53],"method.":[54],"The":[55],"nanomedicines":[57],"were":[58],"stabilized":[59],"by":[60],"integration":[62],"a":[64,152],"single":[65],"boronic":[66],"acid":[67,165],"due":[70],"to":[71],"increased":[73,127],"affinity":[74],"based":[75],"on":[76,167],"multiple":[77],"intermolecular":[78],"interactions.":[79],"We":[80],"found":[81],"P-PTX":[84,118],"exhibited":[86],"superior":[87],"colloidal":[88],"stability":[89,122],"over":[90],"through":[94],"nanoprecipitation":[96],"approach,":[97],"achieving":[98],"longer":[99],"in":[100,107],"vivo":[101],"circulation":[102],"time":[103],"higher":[105],"concentration":[106],"tumor":[108,140],"than":[109],"those":[110],"marketed":[113],"Abraxane\u00ae.":[114],"Furthermore,":[115],"enhanced":[124],"intratumoral":[125],"enrichment,":[126],"maximum":[129],"tolerated":[130],"dose":[131],"PTX,":[133],"remarkably":[134],"suppressed":[135],"growth":[137],"breast":[139],"lung":[142],"metastasis,":[143],"prolonged":[145],"survival":[146],"melanoma":[148],"tumors-bearing":[149],"mice.":[150],"Such":[151],"convenient":[153],"effective":[155],"system":[156],"gains":[157],"insight":[159],"into":[160],"impact":[162],"group":[166],"NPs,":[171],"provides":[173],"potent":[174],"strategy":[175],"for":[176],"rational":[178],"design":[179],"antitumor":[182],"nanomedicines.":[183]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4322492433","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2023-02-28T00:00:00"}
